7-100803532-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6_ModerateBS2
The NM_004444.5(EPHB4):c.2893G>A(p.Val965Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 1,449,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004444.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHB4 | NM_004444.5 | c.2893G>A | p.Val965Ile | missense_variant | 17/17 | ENST00000358173.8 | NP_004435.3 | |
EPHB4 | XM_017011816.2 | c.2947G>A | p.Val983Ile | missense_variant | 17/17 | XP_016867305.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHB4 | ENST00000358173.8 | c.2893G>A | p.Val965Ile | missense_variant | 17/17 | 1 | NM_004444.5 | ENSP00000350896 | P1 | |
EPHB4 | ENST00000360620.7 | c.2737G>A | p.Val913Ile | missense_variant | 16/16 | 1 | ENSP00000353833 | |||
EPHB4 | ENST00000487222.5 | n.4094G>A | non_coding_transcript_exon_variant | 16/16 | 1 | |||||
EPHB4 | ENST00000616502.4 | c.*1358G>A | 3_prime_UTR_variant | 14/14 | 5 | ENSP00000482702 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000871 AC: 2AN: 229630Hom.: 0 AF XY: 0.0000162 AC XY: 2AN XY: 123622
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1449232Hom.: 0 Cov.: 30 AF XY: 0.00000556 AC XY: 4AN XY: 719170
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at